
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PARD3B CRISPR/Cas9 KO Plasmid (h) | sc-406097 | 20 µg | $397.00 |
PARD3B (PAR-3 family cell polarity regulator beta) is a scaffolding protein that contributes to the establishment and maintenance of apical–basal polarity in epithelial cells by organizing polarity complexes at tight junctions. It functions within conserved polarity networks involving PAR proteins and small GTPase signaling to coordinate asymmetric protein localization, junctional integrity, and cytoskeletal organization. Through these processes, PARD3B influences cell migration, tissue architecture, and signaling compartmentalization that can modulate proliferation and differentiation programs. Dysregulation of polarity regulators, including PARD3B-associated pathways, is frequently studied in the context of epithelial disorganization, invasion-related phenotypes, and other disease-relevant cellular states.
PARD3B CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PARD3B gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PARD3B together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PARD3B open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PARD3B protein expression.
This CRISPR knockout system enables efficient generation of PARD3B-deficient cell models for investigation of PARD3B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.